menu
    • menu

    Company profile for SwanBio Therapeutics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    With offices in Philadelphia and Boston, SwanBio Therapeutics is developing leading-edge therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by an unrelenting passion to solve difficult challenges, and a belief that meaningful discovery is borne of curiosity, collaboration, and compassion. Founded by proven industry leaders with a commitment to positively impacting the l...
    With offices in Philadelphia and Boston, SwanBio Therapeutics is developing leading-edge therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by an unrelenting passion to solve difficult challenges, and a belief that meaningful discovery is borne of curiosity, collaboration, and compassion. Founded by proven industry leaders with a commitment to positively impacting the lives of people with neurological diseases, SwanBio merges clinical, scientific and drug commercialization expertise.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SwanBio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    150 Monument Rd Bala Cynwyd PA 19004
    Telephone
    Telephone
    +1 (267) 417-6356
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.swanbiotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/swanbio-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/swanbiotx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SwanBio Appointed Executive Chair and Chief Operating Officer
    SwanBio Appointed Executive Chair and Chief Operating Officer

    16 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231016648148/en

    BUSINESSWIRE
    16 Oct 2023
    Share Share
    SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy
    SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy

    04 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231004099380/en

    BUSINESSWIRE
    04 Oct 2023
    Share Share
    SwanBio Unveils Research in Next Generation CNS Capsids at ASGCT
    SwanBio Unveils Research in Next Generation CNS Capsids at ASGCT

    18 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230518005359/en

    BUSINESSWIRE
    18 May 2023
    Share Share
    SwanBio Therapeutics Confirms Substantial Burden of Disease of (AMN)
    SwanBio Therapeutics Confirms Substantial Burden of Disease of (AMN)

    10 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230510005288/en

    BUSINESSWIRE
    10 May 2023
    Share Share
    SwanBio Therapeutics initiates Phase I/II trial of gene therapy for AMN
    SwanBio Therapeutics initiates Phase I/II trial of gene therapy for AMN

    16 Dec 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/swanbio-therapeutics-gene-therapy/

    CLINICALTRIALSARENA
    16 Dec 2022
    Share Share
    SwanBio Therapeutics Initiates First-in-Human Study of AAV Gene Therapy
    SwanBio Therapeutics Initiates First-in-Human Study of AAV Gene Therapy

    15 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221215005320/en

    BUSINESSWIRE
    15 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search